Main Approaches to Enhance Radiosensitization in Cancer Cells by Nanoparticles: A Systematic Review

Overview

Journal Adv Pharm Bull

Date 2021 Apr 21

PMID 33880343

Citations 7

Authors

Behnaz Babaye Abdollahi

Reza Malekzadeh

Fatemeh Pournaghi Azar

Fatemeh Salehnia

Ali Reza Naseri

Marjan Ghorbani

Hamed Hamishehkar

Ali Reza Farajollahi

Affiliations

Soon will be listed here.

Abstract

In recent years, high atomic number nanoparticles (NPs) have emerged as promising radio-enhancer agents for cancer radiation therapy due to their unique properties. Multi-disciplinary studies have demonstrated the potential of NPs-based radio-sensitizers to improve cancer therapy and tumor control at cellular and molecular levels. However, studies have shown that the dose enhancement effect of the NPs depends on the beam energy, NPs type, NPs size, NPs concentration, cell lines, and NPs delivery system. It has been believed that radiation dose enhancement of NPs is due to the three main mechanisms, but the results of some simulation studies failed to comply well with the experimental findings. Thus, this study aimed to quantitatively evaluate the physical, chemical, and biological factors of the NPs. An organized search of PubMed/Medline, Embase, ProQuest, Scopus, Cochrane and Google Scholar was performed. In total, 77 articles were thoroughly reviewed and analyzed. The studies investigated 44 different cell lines through 70 and 4 studies. A total of 32 different types of single or core-shell NPs in different sizes and concentrations have been used in the studies.

Citing Articles

Understanding the molecular mechanism responsible for developing therapeutic radiation-induced radioresistance of rectal cancer and improving the clinical outcomes of radiotherapy - A review.

Jain S, Nagainallur Ravichandran S, Kumar M, Banerjee A, Sun-Zhang A, Zhang H Cancer Biol Ther. 2024; 25(1):2317999.

PMID: 38445632 PMC: 10936619. DOI: 10.1080/15384047.2024.2317999.

Iron Oxide Nanoparticles in Cancer Treatment: Cell Responses and the Potency to Improve Radiosensitivity.

Shestovskaya M, Luss A, Bezborodova O, Makarov V, Keskinov A Pharmaceutics. 2023; 15(10).

PMID: 37896166 PMC: 10610190. DOI: 10.3390/pharmaceutics15102406.

Recent Metal Nanotheranostics for Cancer Diagnosis and Therapy: A Review.

Khorasani A, Shahbazi-Gahrouei D, Safari A Diagnostics (Basel). 2023; 13(5).

PMID: 36899980 PMC: 10000685. DOI: 10.3390/diagnostics13050833.

Synthesis and characterization of actively HER-2 Targeted FeO@Au nanoparticles for molecular radiosensitization of breast cancer.

Babaye Abdollahi B, Ghorbani M, Hamishehkar H, Malekzadeh R, Farajollahi A Bioimpacts. 2023; 13(1):17-29.

PMID: 36816996 PMC: 9923814. DOI: 10.34172/bi.2022.23682.

Cytotoxic and Radiosensitizing Effects of Folic Acid-Conjugated Gold Nanoparticles and Doxorubicin on Colorectal Cancer Cells.

Heshmatian B, Behrouzkia Z, Mohammadian M, Moradi Z, Mohammadi Z, Zohdi Aghdam R Adv Pharm Bull. 2022; 12(4):772-779.

PMID: 36415636 PMC: 9675912. DOI: 10.34172/apb.2022.079.

References

Engels E, Corde S, McKinnon S, Incerti S, Konstantinov K, Rosenfeld A . Optimizing dose enhancement with TaO nanoparticles for synchrotron microbeam activated radiation therapy. Phys Med. 2016; 32(12):1852-1861. DOI: 10.1016/j.ejmp.2016.10.024. View

Riley P . Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 1994; 65(1):27-33. DOI: 10.1080/09553009414550041. View

Zhao D, Sun X, Tong J, Ma J, Bu X, Xu R . A novel multifunctional nanocomposite C225-conjugated Fe3O4/Ag enhances the sensitivity of nasopharyngeal carcinoma cells to radiotherapy. Acta Biochim Biophys Sin (Shanghai). 2012; 44(8):678-84. DOI: 10.1093/abbs/gms051. View

Conde J, Doria G, Baptista P . Noble metal nanoparticles applications in cancer. J Drug Deliv. 2011; 2012:751075. PMC: 3189598. DOI: 10.1155/2012/751075. View

Antunes F, Cadenas E . Cellular titration of apoptosis with steady state concentrations of H(2)O(2): submicromolar levels of H(2)O(2) induce apoptosis through Fenton chemistry independent of the cellular thiol state. Free Radic Biol Med. 2001; 30(9):1008-18. DOI: 10.1016/s0891-5849(01)00493-2. View

Yang W, Read P, Mi J, Baisden J, Reardon K, Larner J . Semiconductor nanoparticles as energy mediators for photosensitizer-enhanced radiotherapy. Int J Radiat Oncol Biol Phys. 2008; 72(3):633-5. DOI: 10.1016/j.ijrobp.2008.06.1916. View

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009; 151(4):264-9, W64. DOI: 10.7326/0003-4819-151-4-200908180-00135. View

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

Jain S, Coulter J, Butterworth K, Hounsell A, McMahon S, Hyland W . Gold nanoparticle cellular uptake, toxicity and radiosensitisation in hypoxic conditions. Radiother Oncol. 2014; 110(2):342-7. DOI: 10.1016/j.radonc.2013.12.013. View

10.

Su X, Liu P, Wu H, Gu N . Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy. Cancer Biol Med. 2014; 11(2):86-91. PMC: 4069802. DOI: 10.7497/j.issn.2095-3941.2014.02.003. View

11.

Landsiedel R, Kapp M, Schulz M, Wiench K, Oesch F . Genotoxicity investigations on nanomaterials: methods, preparation and characterization of test material, potential artifacts and limitations--many questions, some answers. Mutat Res. 2008; 681(2-3):241-258. DOI: 10.1016/j.mrrev.2008.10.002. View

12.

Mesbahi A, Jamali F, Garehaghaji N . Effect of photon beam energy, gold nanoparticle size and concentration on the dose enhancement in radiation therapy. Bioimpacts. 2013; 3(1):29-35. PMC: 3648909. DOI: 10.5681/bi.2013.002. View

13.

Joh D, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma P . Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. PLoS One. 2013; 8(4):e62425. PMC: 3640092. DOI: 10.1371/journal.pone.0062425. View

14.

Mortezazadeh T, Gholibegloo E, Alam N, Dehghani S, Haghgoo S, Ghanaati H . Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies. MAGMA. 2019; 32(4):487-500. DOI: 10.1007/s10334-019-00738-2. View

15.

Coulter J, Jain S, Butterworth K, Taggart L, Dickson G, McMahon S . Cell type-dependent uptake, localization, and cytotoxicity of 1.9 nm gold nanoparticles. Int J Nanomedicine. 2012; 7:2673-85. PMC: 3373299. DOI: 10.2147/IJN.S31751. View

16.

Hauser A, Mitov M, Daley E, McGarry R, Anderson K, Hilt J . Targeted iron oxide nanoparticles for the enhancement of radiation therapy. Biomaterials. 2016; 105:127-135. PMC: 5321199. DOI: 10.1016/j.biomaterials.2016.07.032. View

17.

Cui F, Li R, Liu Q, Wu P, Hu W, Yue G . Enhancement of radiotherapy efficacy by docetaxel-loaded gelatinase-stimuli PEG-Pep-PCL nanoparticles in gastric cancer. Cancer Lett. 2013; 346(1):53-62. DOI: 10.1016/j.canlet.2013.12.002. View

18.

Her S, Jaffray D, Allen C . Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements. Adv Drug Deliv Rev. 2015; 109:84-101. DOI: 10.1016/j.addr.2015.12.012. View

19.

Jin C, Wu H, Liu J, Bai L, Guo G . The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells. J Clin Pharm Ther. 2007; 32(1):41-7. DOI: 10.1111/j.1365-2710.2007.00796.x. View

20.

Saberi A, Shahbazi-Gahrouei D, Abbasian M, Fesharaki M, Baharlouei A, Arab-Bafrani Z . Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells. Int J Radiat Biol. 2016; 93(3):315-323. DOI: 10.1080/09553002.2017.1242816. View